Efficacy and Safety of OMS103HP in Patients Undergoing Autograft Anterior Cruciate Ligament (ACL) Reconstruction

NCT00226772 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

326

Enrollment

INDUSTRY

Sponsor class

Conditions

Knee Injuries

Interventions

DRUG: OMS103HP
DRUG: Vehicle

Sponsor

Omeros Corporation